Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -14.76%1.38B | -3.95%2.02B | 42.02%1.61B | -10.84%2.1B | -4.71%1.14B | -56.33%2.36B | -64.86%1.19B | -6.26%5.4B | -5.64%3.4B | -30.51%5.76B |
| Operating income | -14.76%1.38B | -3.95%2.02B | 42.02%1.61B | -10.84%2.1B | -4.71%1.14B | -56.33%2.36B | -64.86%1.19B | -6.26%5.4B | -5.64%3.4B | -30.51%5.76B |
| Cost of sales | 26.34%-1.37B | -29.40%-2.21B | -84.79%-1.86B | 10.25%-1.71B | -1.13%-1.01B | 59.05%-1.9B | 64.11%-995.36M | -9.79%-4.64B | -14.62%-2.77B | 31.65%-4.23B |
| Operating expenses | 26.34%-1.37B | -29.40%-2.21B | -84.79%-1.86B | 10.25%-1.71B | -1.13%-1.01B | 59.05%-1.9B | 64.11%-995.36M | -9.79%-4.64B | -14.62%-2.77B | 31.65%-4.23B |
| Gross profit | 102.53%6.22M | -148.02%-189.74M | -288.54%-245.57M | -13.34%395.11M | -34.11%130.25M | -39.62%455.92M | -68.23%197.67M | -50.64%755.05M | -47.23%622.21M | -27.16%1.53B |
| Selling expenses | 31.37%-28.68M | 40.46%-64.74M | 28.02%-41.78M | 18.82%-108.73M | 21.57%-58.05M | 63.43%-133.94M | 63.55%-74.02M | 9.86%-366.3M | -27.37%-203.09M | 15.90%-406.39M |
| Administrative expenses | -1.01%-87.52M | 20.20%-202.86M | 7.93%-86.65M | 10.10%-254.19M | 10.89%-94.11M | 35.23%-282.74M | 49.08%-105.6M | 14.36%-436.54M | -0.02%-207.4M | 13.71%-509.75M |
| Revaluation surplus | 25.04%-149.37M | -11.64%-414.88M | -21.88%-199.27M | 35.98%-371.63M | -146.81%-163.49M | -1,016.17%-580.53M | -515.09%-66.24M | -221.96%-52.01M | 115.76%15.96M | -91.95%42.65M |
| -Changes in the fair value of investment property | 25.04%-149.37M | -11.64%-414.88M | -21.88%-199.27M | 35.98%-371.63M | -146.81%-163.49M | -1,016.17%-580.53M | -515.09%-66.24M | -221.96%-52.01M | 115.76%15.96M | -91.95%42.65M |
| Impairment and provision | ---- | -306.69%-907.89M | ---- | 70.92%-223.24M | ---- | 61.90%-767.72M | ---- | -1,208.51%-2.01B | ---- | ---153.99M |
| -Impairment of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---747.85M | ---- | ---- |
| -Other impairment is provision | ---- | -306.69%-907.89M | ---- | 70.92%-223.24M | ---- | 39.41%-767.72M | ---- | -722.85%-1.27B | ---- | ---153.99M |
| Special items of operating profit | 259.78%128.82M | -111.42%-900.4M | 22.68%-80.62M | 17.51%-425.88M | -130.25%-104.27M | 4.30%-516.3M | 75.27%-45.29M | -136.10%-539.51M | -5,759.23%-183.1M | -36.09%1.49B |
| Operating profit | 80.04%-130.53M | -171.15%-2.68B | -125.73%-653.89M | 45.84%-988.56M | -209.85%-289.67M | 31.23%-1.83B | -309.71%-93.49M | -232.93%-2.65B | -93.70%44.58M | -48.72%2B |
| Financing income | 68.78%229.54M | 32.04%461.15M | 2.55%136M | -12.22%349.25M | -13.85%132.62M | -15.16%397.89M | -17.62%153.94M | -24.56%468.99M | -14.30%186.85M | -10.78%621.69M |
| Financing cost | -49.62%-1.24B | -66.19%-3.05B | 18.13%-825.93M | 4.80%-1.83B | -5.81%-1.01B | -21.27%-1.93B | -176.10%-953.45M | -106.86%-1.59B | -12.58%-345.32M | -31.10%-767.68M |
| Share of profits of associates | 95.65%-345K | 99.44%-465K | -141.17%-7.94M | -222.37%-82.43M | -106.33%-3.29M | 424.94%67.37M | 2,185.37%52.02M | -5.98%-20.73M | 155.87%2.28M | -251.79%-19.56M |
| Earning before tax | 15.88%-1.14B | -106.12%-5.27B | -15.61%-1.35B | 22.24%-2.56B | -39.03%-1.17B | 13.39%-3.29B | -653.47%-840.98M | -307.19%-3.79B | -118.15%-111.61M | -54.43%1.83B |
| Tax | 97.06%-9.54M | 15.76%-531.34M | -988.81%-324.82M | -1,924.04%-630.73M | 1,062.37%36.55M | -148.65%-31.16M | 101.89%3.14M | 111.71%64.06M | 53.24%-166.07M | 31.86%-547.25M |
| After-tax profit from continuing operations | 31.61%-1.15B | -81.99%-5.8B | -48.02%-1.68B | 3.95%-3.19B | -35.19%-1.13B | 11.07%-3.32B | -201.72%-837.84M | -390.51%-3.73B | -206.82%-277.69M | -60.07%1.28B |
| Earning after tax | 31.61%-1.15B | -81.99%-5.8B | -48.02%-1.68B | 3.95%-3.19B | -35.19%-1.13B | 11.07%-3.32B | -201.72%-837.84M | -390.51%-3.73B | -206.82%-277.69M | -60.07%1.28B |
| Minority profit | -281.20%-60.49M | -5.86%-211.77M | 48.68%-15.87M | -30.36%-200.04M | -155.05%-30.92M | -168.10%-153.46M | -114.75%-12.12M | -106.77%-57.24M | -69.18%82.18M | -40.02%845.92M |
| Profit attributable to shareholders | 34.60%-1.09B | -87.09%-5.59B | -50.74%-1.66B | 5.62%-2.99B | -33.43%-1.1B | 13.86%-3.16B | -129.45%-825.72M | -938.45%-3.67B | -5,234.54%-359.87M | -75.73%438.04M |
| Basic earnings per share | 33.85%-0.43 | -87.18%-2.19 | -51.16%-0.65 | 5.65%-1.17 | -34.38%-0.43 | 13.89%-1.24 | -128.57%-0.32 | -947.06%-1.44 | -4,566.67%-0.14 | -75.71%0.17 |
| Diluted earnings per share | 33.85%-0.43 | -87.18%-2.19 | -51.16%-0.65 | 5.65%-1.17 | -34.38%-0.43 | 13.89%-1.24 | -128.57%-0.32 | -1,128.57%-1.44 | -4,566.67%-0.14 | -74.55%0.14 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | -- | -- | -- | -- | -- | -- | -- | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.